Orexo Ab Stock Market Value
| ORXOF Stock | USD 1.08 0.00 0.00% |
| Symbol | Orexo |
Orexo AB 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Orexo AB's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Orexo AB.
| 11/03/2024 |
| 12/03/2024 |
If you would invest 0.00 in Orexo AB on November 3, 2024 and sell it all today you would earn a total of 0.00 from holding Orexo AB or generate 0.0% return on investment in Orexo AB over 30 days. Orexo AB is related to or competes with Genomma Lab, Hypera SA, Elanco Animal, SIGA Technologies, Esperion Therapeutics, and Catalent. Orexo AB , a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the ... More
Orexo AB Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Orexo AB's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Orexo AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 28.0 |
Orexo AB Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Orexo AB's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Orexo AB's standard deviation. In reality, there are many statistical measures that can use Orexo AB historical prices to predict the future Orexo AB's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.50) | |||
| Total Risk Alpha | (0.95) | |||
| Treynor Ratio | (0.80) |
Orexo AB Backtested Returns
Orexo AB maintains Sharpe Ratio (i.e., Efficiency) of -0.13, which implies the firm had a -0.13% return per unit of risk over the last 3 months. Orexo AB exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Orexo AB's Coefficient Of Variation of (812.40), risk adjusted performance of (0.09), and Variance of 11.88 to confirm the risk estimate we provide. The company holds a Beta of 0.54, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Orexo AB's returns are expected to increase less than the market. However, during the bear market, the loss of holding Orexo AB is expected to be smaller as well. At this point, Orexo AB has a negative expected return of -0.44%. Please make sure to check Orexo AB's coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and day typical price , to decide if Orexo AB performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.00 |
No correlation between past and present
Orexo AB has no correlation between past and present. Overlapping area represents the amount of predictability between Orexo AB time series from 3rd of November 2024 to 18th of November 2024 and 18th of November 2024 to 3rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Orexo AB price movement. The serial correlation of 0.0 indicates that just 0.0% of current Orexo AB price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Orexo AB lagged returns against current returns
Autocorrelation, which is Orexo AB otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Orexo AB's otc stock expected returns. We can calculate the autocorrelation of Orexo AB returns to help us make a trade decision. For example, suppose you find that Orexo AB has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Orexo AB regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Orexo AB otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Orexo AB otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Orexo AB otc stock over time.
Current vs Lagged Prices |
| Timeline |
Orexo AB Lagged Returns
When evaluating Orexo AB's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Orexo AB otc stock have on its future price. Orexo AB autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Orexo AB autocorrelation shows the relationship between Orexo AB otc stock current value and its past values and can show if there is a momentum factor associated with investing in Orexo AB.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Orexo OTC Stock
Orexo AB financial ratios help investors to determine whether Orexo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Orexo with respect to the benefits of owning Orexo AB security.